# APHEXDA
> **NDA217159** · New Drug Application · Sponsor: AYRMID PHARMA · Approved 2023-09-08
## Drug
- **FDA Application Number:** NDA217159
- **Application type:** New Drug Application
- **Brand name:** APHEXDA
- **Generic name:** MOTIXAFORTIDE
- **Active ingredients:** MOTIXAFORTIDE ACETATE
- **Dosage form:** POWDER
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** AYRMID PHARMA
- **Manufacturer:** Gamida Cell Inc.
- **First approval:** 2023-09-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217159)
---
*AI Analytics · CC0 1.0*